154 related articles for article (PubMed ID: 28742796)
1. Leukocyte telomere length and renal cell carcinoma survival in two studies.
Callahan CL; Schwartz K; Ruterbusch JJ; Shuch B; Graubard BI; Lan Q; Cawthon R; Baccarelli AA; Chow WH; Rothman N; Hofmann JN; Purdue MP
Br J Cancer; 2017 Aug; 117(5):752-755. PubMed ID: 28742796
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of leukocyte telomere length and risk of renal cell carcinoma.
Hofmann JN; Lan Q; Cawthon R; Hosgood HD; Shuch B; Moore LE; Rothman N; Chow WH; Purdue MP
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):997-1000. PubMed ID: 23513041
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte telomere length and
Morais M; Dias F; Resende T; Nogueira I; Oliveira J; Maurício J; Teixeira AL; Medeiros R
Future Oncol; 2020 Jun; 16(18):1245-1255. PubMed ID: 32422075
[No Abstract] [Full Text] [Related]
4. Prediagnosis Leukocyte Telomere Length and Risk of Ovarian Cancer.
Yang M; Prescott J; Poole EM; Rice MS; Kubzansky LD; Idahl A; Lundin E; De Vivo I; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):339-345. PubMed ID: 28209595
[No Abstract] [Full Text] [Related]
5. Long leukocyte telomere length in prostate cancer patients at diagnosis is associated with poor metastasis-free and cancer-specific survival.
Svenson U; Roos G; Wikström P
Tumour Biol; 2017 Feb; 39(2):1010428317692236. PubMed ID: 28222672
[TBL] [Abstract][Full Text] [Related]
6. Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.
Machiela MJ; Hofmann JN; Carreras-Torres R; Brown KM; Johansson M; Wang Z; Foll M; Li P; Rothman N; Savage SA; Gaborieau V; McKay JD; Ye Y; Henrion M; Bruinsma F; Jordan S; Severi G; Hveem K; Vatten LJ; Fletcher T; Koppova K; Larsson SC; Wolk A; Banks RE; Selby PJ; Easton DF; Pharoah P; Andreotti G; Freeman LEB; Koutros S; Albanes D; Mannisto S; Weinstein S; Clark PE; Edwards TE; Lipworth L; Gapstur SM; Stevens VL; Carol H; Freedman ML; Pomerantz MM; Cho E; Kraft P; Preston MA; Wilson KM; Gaziano JM; Sesso HS; Black A; Freedman ND; Huang WY; Anema JG; Kahnoski RJ; Lane BR; Noyes SL; Petillo D; Colli LM; Sampson JN; Besse C; Blanche H; Boland A; Burdette L; Prokhortchouk E; Skryabin KG; Yeager M; Mijuskovic M; Ognjanovic M; Foretova L; Holcatova I; Janout V; Mates D; Mukeriya A; Rascu S; Zaridze D; Bencko V; Cybulski C; Fabianova E; Jinga V; Lissowska J; Lubinski J; Navratilova M; Rudnai P; Szeszenia-Dabrowska N; Benhamou S; Cancel-Tassin G; Cussenot O; Bueno-de-Mesquita HB; Canzian F; Duell EJ; Ljungberg B; Sitaram RT; Peters U; White E; Anderson GL; Johnson L; Luo J; Buring J; Lee IM; Chow WH; Moore LE; Wood C; Eisen T; Larkin J; Choueiri TK; Lathrop GM; Teh BT; Deleuze JF; Wu X; Houlston RS; Brennan P; Chanock SJ; Scelo G; Purdue MP
Eur Urol; 2017 Nov; 72(5):747-754. PubMed ID: 28797570
[TBL] [Abstract][Full Text] [Related]
7. Telomere length in peripheral leukocytes is associated with immune cell tumor infiltration and prognosis in colorectal cancer patients.
Svenson U; Öberg Å; Stenling R; Palmqvist R; Roos G
Tumour Biol; 2016 Aug; 37(8):10877-82. PubMed ID: 26883253
[TBL] [Abstract][Full Text] [Related]
8. White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).
Sturgeon SR; Pilsner JR; Arcaro KF; Ikuma K; Wu H; Kim SM; Chopra-Tandon N; Karpf AR; Ziegler RG; Schairer C; Balasubramanian R; Reckhow DA
Breast Cancer Res; 2017 Aug; 19(1):94. PubMed ID: 28821281
[TBL] [Abstract][Full Text] [Related]
9. Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer.
Julin B; Shui I; Heaphy CM; Joshu CE; Meeker AK; Giovannucci E; De Vivo I; Platz EA
Br J Cancer; 2015 Feb; 112(4):769-76. PubMed ID: 25562437
[TBL] [Abstract][Full Text] [Related]
10. Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial.
Lotan Y; Karam JA; Shariat SF; Gupta A; Roupret M; Bensalah K; Margulis V
Urol Oncol; 2016 Apr; 34(4):167.e9-16. PubMed ID: 26602092
[TBL] [Abstract][Full Text] [Related]
11. LINE1 methylation levels in pre-diagnostic leukocyte DNA and future renal cell carcinoma risk.
Karami S; Andreotti G; Liao LM; Pfeiffer RM; Weinstein SJ; Purdue MP; Hofmann JN; Albanes D; Mannisto S; Moore LE
Epigenetics; 2015; 10(4):282-92. PubMed ID: 25647181
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte Telomere Length and All-Cause, Cardiovascular Disease, and Cancer Mortality: Results From Individual-Participant-Data Meta-Analysis of 2 Large Prospective Cohort Studies.
Mons U; Müezzinler A; Schöttker B; Dieffenbach AK; Butterbach K; Schick M; Peasey A; De Vivo I; Trichopoulou A; Boffetta P; Brenner H
Am J Epidemiol; 2017 Jun; 185(12):1317-1326. PubMed ID: 28459963
[TBL] [Abstract][Full Text] [Related]
13. Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohorts.
Seow WJ; Cawthon RM; Purdue MP; Hu W; Gao YT; Huang WY; Weinstein SJ; Ji BT; Virtamo J; Hosgood HD; Bassig BA; Shu XO; Cai Q; Xiang YB; Min S; Chow WH; Berndt SI; Kim C; Lim U; Albanes D; Caporaso NE; Chanock S; Zheng W; Rothman N; Lan Q
Cancer Res; 2014 Aug; 74(15):4090-8. PubMed ID: 24853549
[TBL] [Abstract][Full Text] [Related]
14. Shorter Treatment-Naïve Leukocyte Telomere Length is Associated with Poorer Overall Survival of Patients with Pancreatic Ductal Adenocarcinoma.
Antwi SO; Bamlet WR; Cawthon RM; Rabe KG; Druliner BR; Sicotte H; Jatoi A; Mahipal A; Boardman LA; Oberg AL; Petersen GM
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):210-216. PubMed ID: 33187969
[TBL] [Abstract][Full Text] [Related]
15. Plasma vitamin D biomarkers and leukocyte telomere length in men.
Julin B; Shui IM; Prescott J; Giovannucci EL; De Vivo I
Eur J Nutr; 2017 Mar; 56(2):501-508. PubMed ID: 26558766
[TBL] [Abstract][Full Text] [Related]
16. U-Shaped Relationship of Leukocyte Telomere Length With All-Cause and Cancer-Related Mortality in Older Men.
Yeap BB; Hui J; Knuiman MW; Flicker L; Divitini ML; Arscott GM; Twigg SM; Almeida OP; Hankey GJ; Golledge J; Norman PE; Beilby JP
J Gerontol A Biol Sci Med Sci; 2021 Jan; 76(1):164-171. PubMed ID: 32761187
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in Hong Kong Chinese.
Ko JM; Tsang KH; Dai W; Choi SSA; Leong MM; Ngan RK; Kwong DL; Cheng A; Lee AW; Ng WT; Tung S; Lee VH; Lam KO; Chan CK; Lung ML
Int J Cancer; 2018 Nov; 143(9):2289-2298. PubMed ID: 29873071
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
[TBL] [Abstract][Full Text] [Related]
19. Circulating Prostate-Specific Antigen and Telomere Length in a Nationally Representative Sample of Men Without History of Prostate Cancer.
Wulaningsih W; Astuti Y; Matsuguchi T; Anggrandariyanny P; Watkins J;
Prostate; 2017 Jan; 77(1):22-32. PubMed ID: 27566127
[TBL] [Abstract][Full Text] [Related]
20. Short leukocyte telomere length predicts poor prognosis and indicates altered immune functions in colorectal cancer patients.
Chen Y; Qu F; He X; Bao G; Liu X; Wan S; Xing J
Ann Oncol; 2014 Apr; 25(4):869-876. PubMed ID: 24608194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
